Lightstone Ventures
Lightstone Ventures is a leading global venture capital firm.
Business Model:
Revenue: $14.6M
Employees: 51-200
Rankings
Detailed Lightstone Ventures Information
Geographic Data
Address: 485 Ramona St
City: Palo Alto
State: CA
Zip: 94301
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$847M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.
Contact Phone:
+16503883676
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2017 | Cerevance | Series A | 5M |
| 11/2013 | Astria Therapeutics | Series B | 32.4M |
| 2/2019 | Nuvaira | Equity | 79M |
| 1/2019 | Allay Therapeutics | Series B | 25M |
| 4/2016 | Gemini Therapeutics | Seed Round | 2M |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 8/2014 | Claret Medical | Series B | 0 |
| 2/2020 | ALX Oncology | Series C | 105M |
| 10/2020 | Relievant Medsystems | Venture Round | 0 |
| 3/2023 | FIRE1 | Venture Round | 0 |
| 10/2018 | Earlens | Series D | 0 |
| 3/2015 | ALX Oncology | Series A | 36M |
| 12/2020 | Tallac Therapeutics | Series A | 62M |
| 11/2020 | Shoulder Innovations | Venture Round | 0 |
| 9/2022 | Nimbus Therapeutics | Venture Round | 0 |
| 1/2014 | FIRE1 | Series A | - |
| 10/2015 | Elcelyx Therapeutics | Series E | 0 |
| 2/2023 | Cerevance | Series B | 0 |
| 12/2016 | Cerevance | Series A | 21.5M |
| 12/2019 | Willow | Series C | 20M |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 6/2017 | Earlens | Series C | 0 |
| 11/2020 | Catamaran Bio | Series A | 0 |
| 6/2018 | Nimbus Therapeutics | Series B | 65M |
| 2/2021 | Cyteir Therapeutics | Series C | 0 |
| 5/2018 | Medisix Therapeutics | Series A | 20M |
| 12/2022 | Carrick Therapeutics | Series C | 0 |
| 5/2019 | Cala Health | Series C | 0 |
| 1/2022 | ProVerum Medical | Series A | 0 |
| 1/2018 | FIRE1 | Series C | 49.6M |
| 6/2016 | Earlens | Series C | 0 |
| 9/2014 | Flex Pharma | Venture Round | 0 |
| 4/2021 | Alchemab Therapeutics | Series A | 82.7M |
| 3/2015 | Nimbus Therapeutics | Series B | 43M |
| 1/2017 | Allay Therapeutics | Series A | 7M |
| 10/2019 | Cyteir Therapeutics | Series B | 40.2M |
| 4/2014 | Earlens | Series B | 40M |
| 7/2015 | Ra Pharmaceuticals | Series B | 58.5M |
| 5/2019 | Locanabio | Series A | 55M |
| 3/2023 | Relievant Medsystems | Series G | 0 |
| 9/2020 | Willow | Series C | 0 |
| 10/2017 | Claret Medical | Series C | 0 |
| 2/2016 | Cala Health | Series B | 0 |
| 4/2016 | FIRE1 | Series B | 7.5M |
| 3/2017 | ALX Oncology | Convertible Note | 25M |
| 10/2017 | Gemini Therapeutics | Series A | 42.5M |
| 9/2019 | Bold Penguin | Series B | 32M |
| 6/2018 | Relievant Medsystems | Series E | 58M |
| 3/2015 | Nimbus Apollo | Series B | 43M |
| 4/2020 | Cerevance | Series B | 65M |
| 4/2021 | WayCool | Series C | 0 |
| 1/2021 | Ligature Therapeutics | Seed Round | 0 |
| 3/2023 | Shoulder Innovations | Series D | 0 |
| 10/2016 | Carrick Therapeutics | Series A | 95M |
| 1/2023 | Volta Medical | Series B | 0 |
| 12/2021 | Choiceform | Venture Round | 30M |
| 3/2016 | Tizona Therapeutics | Series B | 43M |
| 3/2018 | Cyteir Therapeutics | Series B | 29M |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 65M |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 0 |
| 9/2017 | Disarm Therapeutics | Series A | 30M |
| 12/2020 | Locanabio | Series B | 0 |
| 1/2022 | ProVerum Medical | Series A | 0 |
| 12/2021 | Choiceform | Venture Round | 0 |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 4/2021 | Alchemab Therapeutics | Series A | 0 |
| 4/2021 | WayCool | Series C | 0 |
| 2/2021 | Cyteir Therapeutics | Series C | 0 |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 1/2021 | Ligature Therapeutics | Seed Round | 0 |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 12/2020 | Locanabio | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
